...
首页> 外文期刊>Progress in Cardiovascular Diseases >Echocardiography for Hypertrophic Cardiomyopathy
【24h】

Echocardiography for Hypertrophic Cardiomyopathy

机译:超声心动图治疗肥厚型心肌病

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Hypertrophic cardiomyopathy (HCM) is a genetic cardiomyopathy. The prevalence of phenotypic expression, in the absence of another systemic or cardiac disease causing increased left ventricular (LV) wall thickness, is estimated to be 1:500. The frequency of clinical presentation is far less, highlighting the need for a non-invasive diagnostic imaging tool. Echocardiography is readily available and allows for structural characterization and hemodynamic assessment of the hypertrophic heart and to screen patients at-risk for HCM, such as first degree relatives of affected individuals, and differentiate HCM from the athletic heart. Echocardiography can also be used to assess for anatomic abnormalities of the mitral valve apparatus that may exacerbate LV outflow track obstruction and to further risk stratify patients during exercise. Finally, echocardiography plays an integral role in guiding alcohol septal ablation procedures.
机译:肥厚型心肌病(HCM)是遗传性心肌病。在不存在导致左心室(LV)壁厚度增加的另一种系统性或心脏病性疾病的情况下,表型表达的患病率估计为1:500。临床表现的频率要少得多,这凸显了对非侵入性诊断成像工具的需求。超声心动图很容易获得,可以对肥厚性心脏进行结构表征和血流动力学评估,并筛查有HCM危险的患者(例如患病个体的一级亲属),并将HCM与运动心脏区分开。超声心动图还可用于评估二尖瓣器械的解剖异常,这些解剖异常可能会加重左室流出道梗阻并在运动过程中进一步使患者分层。最后,超声心动图在指导酒精中隔消融手术中起着不可或缺的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号